Axovant Plans Nelotanserin PhIII But Trial Endpoint Has Eyebrows Raised

 
• By Lucie Ellis-Taitt
EraseDementia_1200x675
Axovant will take dementia drug into Phase III later this year • Source: Shutterstock

More from Clinical Trials

More from R&D